20162018

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2018

Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study

van Dalem, J., Brouwers, M. C. G. J., Stehouwer, C. D. A., Krings, A., Klungel, O. H., Driessen, J. H. M., de Vries, F. & Burden, A. M., Apr 2018, In : Diabetes Obesity & Metabolism. 20, 4, p. 1056-1060 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2016

Het risico op hypoglykemieën bij sulfonylureumderivaten ten opzichte van metformine in relatie tot nierfunctie en metabolietgroep

van Dalem, J., Brouwers, M., Stehouwer, C., Krings, A., Leufkens, H. G. M., Driessen, J. H. M., de Vries, F. & Burden, A., 2016, In : Nederlands Platform voor Farmaceutisch Onderzoek. 1, a1636.

Research output: Contribution to journalArticleAcademicpeer-review

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study

van Dalem, J., Brouwers, M. C. G. J., Stehouwer, C. D. A., Krings, A., Leufkens, H. G. M., Driessen, J. H. M., de Vries, F. & Burden, A. M., 13 Jul 2016, In : BMJ (e). 354, i3625.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Use of incretin agents and risk of pancreatic cancer: a population-based cohort study

Knapen, L., van Dalem, J., Keulemans, J., van Erp, N. P., Bazelier, M. T., de Bruin, M. L., Leufkens, H. G., Croes, S., Neef, C., de Vries, F. & Driessen, J. H. M., Mar 2016, In : Diabetes Obesity & Metabolism. 18, 3, p. 258-265 8 p.

Research output: Contribution to journalArticleAcademicpeer-review